Jan 25 (Reuters) - EUROBIO SCIENTIFIC SA ALERS.PA :
* FY REVENUE ROSE 220 PERCENT TO 189 MILLION EUR
* MORE THAN 60% OF THESE SALES (EUR 117M) ARE RELATED TO
COVID-19
DIAGNOSTIC TESTS AND INSTRUMENTS
* GROUP EXPECTS A VERY STRONG IMPROVEMENT IN ITS RESULTS FOR
2020
FINANCIAL YEAR
* VERY SOLID FINANCIAL BASE WITH A CASH POSITION OF AROUND
EUR 65
MILLION AS OF DECEMBER 31, 2020, AND AROUND EUR 25 MILLION OF
OVERALL FINANCIAL DEBT
* INCREASED VISIBILITY AND THESE STRENGTHENED RESOURCES WILL
ENABLE EUROBIO SCIENTIFIC TO ACCELERATE ITS STRATEGIC DEPLOYMENT
Source text for Eikon: ID:nGNE9RwNmS
Further company coverage: ALERS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))